Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,289 public trials 1,200 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC

NCT03736837

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hebei Provincial People's Hospital Shijiazhuang, Hebei, China
  • Neimenggu Autonomous Region People's Hospital Hohhot, Neimenggu, China
  • Neimenggu Medical University Affiliated Hospital Hohhot, Neimenggu, China
  • Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
View Trial Details
Completed

Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment

NCT00606502

Conditions
Behavior, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
View all 47 locations
View Trial Details
Completed

A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

NCT02697591

Conditions
Adenocarcinoma, Advanced Malignancies, Bronchial Neoplasms, +36 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

NCT03380871

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of California - Los Angeles Santa Monica, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details
Completed

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers

NCT02264990

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Clearview Cancer Institute /ID# 131434 Huntsville, Alabama, United States
  • University of South Alabama /ID# 131518 Mobile, Alabama, United States
  • Highlands Oncology Group /ID# 131250 Springdale, Arkansas, United States
  • CBCC Global Research, Inc. at /ID# 132709 Bakersfield, California, United States
View all 140 locations
View Trial Details

Related conditions